Entity
Description
Value proposition
Early Stage MedTech Venture Capital
THENA Capital is supporting MedTech high growth companies that create transformative health experiences. Fund TCX-1 is focused on early stage digital and fast-tracked devices, backing businesses addressing key need spaces across care delivery, patient support, and medical product verticals, from chronic conditions, to women’s health, oncology, and mental health.
THENA Capital aims to change the face of early stage medical technology investment through deep sector and commercialisation expertise.
Catalyst interactions
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 Boeing Aviation & Aerospace | Boeing Aviation & Aerospace | Other 19 Mar 2026 | | |
 Amazon Web Services (AWS) IT services, IT Services and IT Consulting | Amazon Web Services (AWS) IT services, IT Services and IT Consulting | Other 5 Mar 2026 | | |
 NVIDIA Semiconductors, Computer Hardware Manufacturing | NVIDIA Semiconductors, Computer Hardware Manufacturing | Other 5 Mar 2026 | | |
 Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 26 Mar 2026 | | |
 London Stock Exchange Finance, Financial Services | London Stock Exchange Finance, Financial Services | Other 12 Mar 2026 | | |
 Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 16 Dec 2025 | | |
 Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 16 Dec 2025 | | |
 Havas Advertising, Advertising Services | Havas Advertising, Advertising Services | Other 31 Oct 2025 | | |
 Cabinet Office Research, National and local authorities | Cabinet Office Research, National and local authorities | Other 23 Mar 2026 | | |
 Nasdaq Finance, Financial Services | Nasdaq Finance, Financial Services | Other 23 Sep 2025 | | |
Social network dynamics
Last news Show all articles
Loading...